Astrogliosis and the ApoE genotype

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue 4, 1999, Pages 252-257

  Overmyer, Margit ^a   Helisalmi, Seppo ^a,b   Soininen, Hilkka ^a,b   Laakso, Markku ^b   Riekkinen Sr , Paavo ^a   Alafuzoff, Irina ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Apolipoprotein E genotype; Glial fibrillary acidic protein; Neurofibrillary tangles; Senile neuritic plaques

Indexed keywords

APOLIPOPROTEIN E; GLIAL FIBRILLARY ACIDIC PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; ASTROCYTOSIS; AUTOPSY; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASTROCYTES; BRAIN; FEMALE; GENOTYPE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLES; REGRESSION ANALYSIS; SENILE PLAQUES;

EID: 0032968764     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017128     Document Type: Article

References (34)

1. Sulkava R, Amberia K: Alzheimer's disease and senile dementia of Alzheimer type. Acta Neurol Scand 1982;65:651-660.
2. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
3. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
4. Mann DMA, Jones D, Prinja D, Purkiss MS: The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol 1990;80:318-327.
5. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's disease (CERAD). II: Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991 ;41:479-486.
6. Lue LF, Brachova L, Civin WH, Rogers J: Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 1996;55:1083-1088.
7. Dickson DW: The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997;56: 321-339.
8. Mizutani T, Amano N, Sasaki H, Morimatsu Y, Mori H, Yoshimura M, Yamanouchi HY, Hayakawa K, Shimada H: Senile dementia of Alzheimer type characterized by laminar neuronal loss exclusively in the hippocampus, parahippocampus and medial occipitotemporal cortex. Acta Neuropathol 1990;80:575-580.
9. Gomez-Isla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT: Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;16:4491-4500.
10. Biernat W, Liberski PP, Guiroy DC, Yanagihara R, Gajdusek C: Proliferating cell nuclear antigen immunohistochemistry in astrocytes in experimental Creutzfeldt-Jakob disease and in human kuru, Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker syndrome. Neurodegeneration 1995;4:195-201.
11. Hooten WM, Lyketsos CG: Frontotemporal dementia: Clinicopathological review of four postmortem studies. J Neuropsychiatry Clin Neurosci 1996;8:10-19.
12. Wallin A, Blennow K, Rosengren LE: Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia. Dementia 1996;7:267-272.
13. Delacourte A: General and dramatic glial reaction in Alzheimer brains. Neurology 1990;40: 33-37.
14. Le Prince G, Delaere P, Fages C, Duyckaerts C, Hauw J-J, Tardy M: Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type. Neurosci Lett 1993;51:71-73.
15. Brun A, Liu X, Erikson C: Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. Neurodegeneration 1995; 44:171-177.
16. Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE: Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathol 1996;91:269-277.
17. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen S-HC: Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol 1988;132:86-101.
18. Renkawek K, Voorter CEM, Bosman GJCGM, van Workum FPA, de Jong WW: Expression of alpha B-crystalline in Alzheimer's disease. Acta Neuropathol 1994;87:155-160.
19. Harpin ML, Delaère P, Javoy-Agid F, Bock E, Jacque C, Delpech B, Villarroya H, Duyckaerts C, Hauw JJ, Baumann N: Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: Relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles. J Neurosci Res 1990;27:587-594.
20. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-McLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43: 1467-1472.
21. Soininen H, Riekkinen PJ Sr: Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci 1996;19:224-228.
22. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schemechel D, Saunders AM, Goldgaber D, Roses AD: Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:8098-8102.
23. Martinoli MG, Trojanowski JQ, Schmidt ML, Arnold SE, Fujiwara TM, Lee VM-Y, Hurtig H, Julien J-P, Clark C: Association of apolipoprotein ε4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol 1990;90:239-243.
24. Heinonen O, Lehtovirta M, Soininen H, Helisalmi A, Mannermaa A, Sorvari H, Kosunen O, Paljärvi L, Ryynänen M, Riekkinen PJ Sr: Alzheimer pathology of patients carrying apolipoprotein E ε4 allele. Neurobiol Aging 1994; 16:505-513.
25. Nagy ZS, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD: Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 1995;69: 757-761.
26. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K: Apolipoprotein E, dementia and cortical deposition of β-amyloid protein. New Engl J Med 1985;333:1242-1247.
27. Ma J, Yee A, Brewer HB Jr, Das S, Potter H: Amyloid-associated proteins alpha l-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 1994;372:92-94.
28. Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B: Fibrillogenesis in Alzheimer's diesease of amyloid β peptides and apolipoprotein E. Biochem J 1995;306:599-604.
29. Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey W, Haase AT: Neuropathological changes with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 1991;65:4759-4768.
30. Oropeza RL, Wekerle H, Werb Z: Expression of apolipoprotein E by mouse brain astrocytes and its modulation by interferon-gamma. Brain Res 1987;410:45-51.
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
32. Hixon JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31: 545-548.
33. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, Kurokawa K, Teramoto T: Determination by PCR-RFLP of apoE genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
34. Mölsä PK, Sako E, Paljärvi L, Rinne JO, Rinne UK: Alzheimer's disease: Neuoropathological correlations of cognitive and motor disorders. Acta Neurol Scand 1987;75:376-384.